Human buccal plate extraction socket regeneration with recombinant human platelet-Derived growth factor BB or enamel matrix derivative

International Journal of Periodontics and Restorative Dentistry

Volumn 31, Issue 5, 2011, Pages 481-492

  Nevins, Marc L ^a   Camelo, Marcelo ^b   Schupbach, Peter ^c   Nevins, Myron ^a   Kim, Soo Woo ^a   Kim, David M ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b Institute for Advanced Dental Studies   (Brazil)

^c Research Laboratory for Implants and Biomaterials   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; COLLAGEN; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR BB; TISSUE SCAFFOLD;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; BONE DENSITY; BONE DEVELOPMENT; BONE PROSTHESIS; BONE REGENERATION; CERAMICS; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FOLLOW UP; HUMAN; JAW; MIDDLE AGED; PATHOLOGY; PLASTIC SURGERY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCANNING ELECTRON MICROSCOPY; TOOTH EXTRACTION; TOOTH IMPLANTATION; TOOTH SOCKET; TREATMENT OUTCOME; WOUND HEALING;

ADOLESCENT; ADULT; AGED; ALVEOLAR PROCESS; ANGIOGENESIS INDUCING AGENTS; BIOPSY; BONE DENSITY; BONE REGENERATION; BONE SUBSTITUTES; CERAMICS; COHORT STUDIES; COLLAGEN; DENTAL ENAMEL PROTEINS; DENTAL IMPLANTATION, ENDOSSEOUS; FOLLOW-UP STUDIES; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; OSTEOGENESIS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS C-SIS; SURGICAL FLAPS; TISSUE SCAFFOLDS; TOOTH EXTRACTION; TOOTH SOCKET; TREATMENT OUTCOME; WOUND HEALING; YOUNG ADULT;

EID: 84879790220     PISSN: 01987569     EISSN: 19453388     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Howell TH, Fiorellini JP, Paquette DW, Offenbacher S, Giannobile WV, Lynch SE. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997; 68: 1186-1193.
2. Camelo M, Nevins ML, Schenk RK, Lynch SE, Nevins M. Periodontal regeneration in human Class II furcations using purified recombinant human platelet-derived growth factor-BB (rhPDGF-BB) with bone allograft. Int J Periodontics Restorative Dent 2003; 23: 213-225.
3. Nevins M, Camelo M, Nevins ML, Schenk RK, Lynch SE. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone. J Periodontol 2003; 74: 1282-1292.
4. Nevins M, Giannobile WV, McGuire MK, et al. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: Results of a large multicenter randomized controlled trial. J Periodontol 2005; 76: 2205-2215.
5. Simion M, Rocchietta I, Kim D, Nevins M, Fiorellini J. Vertical ridge augmentation by means of deproteinized bovine bone block and recombinant human plateletderived growth factor-BB: A histologic study in a dog model. Int J Periodontics Restorative Dent 2006; 26: 415-423.
6. Simion M, Nevins M, Rocchietta I, et al. Vertical ridge augmentation using an equine block infused with recombinant human platelet-derived growth factor-BB: A histologic study in a canine model. Int J Periodontics Restorative Dent 2009; 29: 245-255.
7. Nevins M, Garber D, Hanratty JJ, et al. Human histologic evaluation of anorganic bovine bone mineral combined with recombinant human plateletderived growth factor BB in maxillary sinus augmentation: Case series study. Int J Periodontics Restorative Dent 2009; 29: 583-591.
8. McGuire MK, Scheyer T, Nevins M, Schupbach P. Evaluation of human recession defects treated with coronally advanced flaps and either purified recombinant human platelet-derived growth factor-BB with beta tricalcium phosphate or connective tissue: A histologic and microcomputed tomographic examination. Int J Periodontics Restorative Dent 2009; 29: 7-21.
9. Simion M, Rocchietta I, Dellavia C. Threedimensional ridge augmentation with xenograft and recombinant human platelet- derived growth factor-BB in humans:Report of two cases. Int J Periodontics Restorative Dent 2007; 27: 109-115.
10. Simion M, Rocchietta I, Monforte M, Maschera E. Three-dimensional alveolar bone reconstruction with a combination of recombinant human platelet-derived growth factor BB and guided bone regeneration:A case report. Int J Periodontics Restorative Dent 2008; 28: 239-243.
11. Fagan MC, Miller RE, Lynch SE, Kao RT. Simultaneous augmentation of hard and soft tissues for implant site preparation using recombinant human plateletderived growth factor: A human case report. Int J Periodontics Restorative Dent 2008; 28: 37-43.
12. Rosen PS, Toscano N, Holzclaw D, Reynolds M. A retrospective consecutive case series using mineralized allograft with recombinant human platelet-derived growth factor BB to treat moderate to severe osseous lesions. Int J Periodontics Restorative Dent 2011; 31: 335-341.
13. Nevins ML, Camelo M, Schupbach P, Kim DM, Camelo JM, Nevins M. Human histologic evaluation of mineralized collagen bone substitute and recombinant platelet-derived growth factor-BB to create bone for implant placement in extraction socket defects at 4 and 6 months: A case series. Int J Periodontics Restorative Dent 2009; 29: 129-139.
14. Giannobile WV, Somerman MJ. Growth and amelogenin-like factors in periodontal wound healing. A systematic review. Ann Periodontol 2003; 8: 193-204.
15. Sculean A, Chiantella GC, Arweiler NB, Becker J, Schwarz F, Stavropoulos A. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral. Int J Periodontics Restorative Dent 2008; 28: 153-161.
16. Esposito M, Grusovin MG, Papanikolaou N, Coulthard P, Worthington HV. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review. Eur J Oral Implantol 2009; 2: 247-266.
17. Grusovin MG, Esposito M. The efficacy of enamel matrix derivative (Emdogain) for the treatment of deep infrabony periodontal defects: A placebo-controlled randomised clinical trial. Eur J Oral Implantol 2009; 2: 43-54.
18. Listl S, Tu YK, Faggion CM Jr. A costeffectiveness evaluation of enamel matrix derivatives alone or in conjunction with regenerative devices in the treatment of periodontal intra-osseous defects. J Clin Periodontol 2010; 37: 920-927.